Analysts think CRIS stock price could increase by 288%
Jul 28, 2024, 6:27 AM
6.12%
What does CRIS do
Curis Inc, based in Lexington, Massachusetts, specializes in biotechnology, focusing on developing cancer therapies, including its lead drug, Emavusertib, which targets IRAK4 kinase. Established in 2000 and employing 51 people, Curis also has other programs like Erivedge, which inhibits the Hedgehog signaling pathway, and CI-8993 targeting VISTA protein.
6 analysts think CRIS stock price will increase by 287.77%. The current median analyst target is $23.46 compared to a current stock price of $6.05. The lowest analysts target is $18.18 and the highest analyst target is $27.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.